Prevalence of incidental prostate cancer: A systematic review of autopsy studies.
Reads0
Chats0
TLDR
There is a substantial reservoir of incidental prostate cancer which increases with age, and the high risk of overdiagnosis limits the usefulness of prostate cancer screening.Abstract:
Prostate cancer screening may detect nonprogressive cancers, leading to overdiagnosis and overtreatment. The potential for overdiagnosis can be assessed from the reservoir of prostate cancer in autopsy studies that report incidental prostate cancer rates in men who died of other causes. We aimed to estimate the age-specific incidental cancer prevalence from all published autopsy studies. We identified eligible studies by searches of Medline and Embase, forward and backward citation searches and contacting authors. We screened the titles and abstracts of all articles; checked the full-text articles for eligibility and extracted clinical and pathology data using standardized forms. We extracted mean cancer prevalence, age-specific cancer prevalence and validity measures and then pooled data from all studies using logistic regression models with random effects. The 29 studies included in the review dated from 1948 to 2013. Incidental cancer was detected in all populations, with no obvious time trends in prevalence. Prostate cancer prevalence increased with each decade of age, OR 51.7 (1.6–1.8), and was higher in studies that used the Gleason score, OR 52.0 (1.1–3.7). No other factors were significantly predictive. The estimated mean cancer prevalence increased in a nonlinear fashion from 5% (95% CI: 3–8%) at age 79 years. There was substantial variation between populations in estimated cancer prevalence. There is a substantial reservoir of incidental prostate cancer which increases with age. The high risk of overdiagnosis limits the usefulness of prostate cancer screening.read more
Citations
More filters
Journal ArticleDOI
Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer
Frankâ€Jan H Drost,Daniël F Osses,Daan Nieboer,Ewout W. Steyerberg,Chris H. Bangma,Monique J. Roobol,Ivo G. Schoots +6 more
TL;DR: The diagnostic accuracy of the index tests MRI only, MRI-targeted biopsy, the MRI pathway and systematic biopsy as compared to template-guidedBiopsy as the reference standard in detecting clinically significant prostate cancer as the target condition was determined.
Journal ArticleDOI
Exosome-based liquid biopsies in cancer: opportunities and challenges.
W. Yu,James Hurley,D. Roberts,Sudipto K. Chakrabortty,D. Enderle,Mikkel Noerholm,Xandra O. Breakefield,Johan Skog +7 more
TL;DR: In this article, the authors discuss the advantages and challenges of exosome-based liquid biopsies for tumor biomarkers and clinical implementation in the context of circulating tumor DNA and circulating tumor cells.
Journal ArticleDOI
Current evidence on the effect of dietary polyphenols intake on chronic diseases
Chiara Costa,Aristidis Tsatsakis,Charalampos Mamoulakis,Michele Teodoro,Giusi Briguglio,Emanuela Caruso,Dimitris Tsoukalas,Denisa Margina,Efthimios Dardiotis,Demetrios Kouretas,Concettina Fenga +10 more
TL;DR: This comprehensive review of the current evidence defining the position of polyphenols in the prevention/treatment of human chronic diseases, including prostate cancer and other types of cancer, cardiovascular diseases, diabetes mellitus and neurodegenerative diseases such as Alzheimer's and Parkinson's disease focuses on their ability to modulate multiple signalling transduction pathways involved in the pathophysiology of these diseases.
Journal ArticleDOI
Label-free isolation of prostate circulating tumor cells using Vortex microfluidic technology
Corinne Renier,Edward Pao,James Che,Haiyan E. Liu,Clementine A. Lemaire,Melissa Matsumoto,Melanie Triboulet,Sandy Srivinas,Stefanie S. Jeffrey,Matthew B. Rettig,Matthew B. Rettig,Rajan P. Kulkarni,Dino Di Carlo,Dino Di Carlo,Elodie Sollier-Christen +14 more
TL;DR: A microfluidic device can rapidly and efficiently isolate circulating tumor cells from the blood of prostate cancer patients and show that the purity and DNA yield of isolated cells is amenable to targeted amplification and next-generation sequencing, without whole genome amplification.
Journal ArticleDOI
Global incidence of prostate cancer in developing and developed countries with changing age structures.
TL;DR: Projections showed that the aging-adjusted incidence rates of prostate cancer in Asia and the developing Western countries were expected to increase in much larger extents than the developed Western countries.
References
More filters
Journal ArticleDOI
Overdiagnosis in Cancer
TL;DR: The two prerequisites for cancer overdiagnosis to occur are described: the existence of a silent disease reservoir and activities leading to its detection (particularly cancer screening), and the magnitude of over diagnosis from randomized trials.
Journal ArticleDOI
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
Fritz H. Schröder,Jonas Hugosson,Monique J. Roobol,Teuvo L.J. Tammela,Marco Zappa,Vera Nelen,Maciej Kwiatkowski,Marcos Lujan,Liisa Määttänen,Hans Lilja,Louis Denis,Franz Recker,Alvaro Paez,Chris H. Bangma,Sigrid Carlsson,Sigrid Carlsson,Donella Puliti,Arnauld Villers,Xavier Rebillard,Matti Hakama,Ulf-Håkan Stenman,Paula Kujala,Kimmo Taari,Gunnar Aus,Andreas R. Huber,Theo van der Kwast,Ron H.N. van Schaik,Harry J. de Koning,Sue Moss,Anssi Auvinen +29 more
TL;DR: In this update the ERSPC confirms a substantial reduction in prostate cancer mortality attributable to testing of PSA, with a substantially increased absolute effect at 13 years compared with findings after 9 and 11 years.
Journal ArticleDOI
The Frequency of Carcinoma and Intraepithelial Neoplasia of the Prostate in Young Male Patients
TL;DR: Prostatic intraepithelial neoplasia and histological cancers are surprisingly common in young male patients of both races, and appears to present several decades earlier than clinically detected carcinoma.
Journal ArticleDOI
Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France.
Breslow N,Chan Cw,Dhom G,Drury Ra,Franks Lm,Gellei B,Lee Ys,Lundberg S,Sparke B,Sternby Nh,Tulinius H +10 more
TL;DR: Two Chinese populations showed a low frequency of latent carcinoma in comparison with western Europeans in Sweden and the Federal Republic of Germany and negroes from Jamaica; an intermediate position was found for Israelis and black Ugandans.
Related Papers (5)
EAU–ESTRO–SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet,Joaquim Bellmunt,Michel Bolla,Erik Briers,Marcus G. Cumberbatch,Maria De Santis,Nicola Fossati,Tobias Gross,Ann Henry,Steven Joniau,Thomas B. Lam,Thomas B. Lam,Malcolm David Mason,Vsevolod Matveev,Paul C. Moldovan,Roderick C.N. van den Bergh,Thomas Van den Broeck,Henk G. van der Poel,Theo H. van der Kwast,Olivier Rouvière,Ivo G. Schoots,Thomas Wiegel,Philip Cornford +22 more